{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T21:36:04Z","timestamp":1782941764523,"version":"3.54.5"},"reference-count":41,"publisher":"Impact Journals, LLC","issue":"46","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2016,11,15]]},"DOI":"10.18632\/oncotarget.11820","type":"journal-article","created":{"date-parts":[[2016,9,2]],"date-time":"2016-09-02T08:52:43Z","timestamp":1472806363000},"page":"74987-74999","source":"Crossref","is-referenced-by-count":8,"title":["Anti-hepatocellular carcinoma properties of the anti-alcoholism drug disulfiram discovered to enzymatically inhibit the AMPK-related kinase SNARK <i>in vitro<\/i>"],"prefix":"10.18632","volume":"7","author":[{"given":"Kaku","family":"Goto","sequence":"first","affiliation":[{"name":"The Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Kato","sequence":"additional","affiliation":[{"name":"The Advanced Clinical Research Center, The Institute of Medical Science, The University of Tokyo, Tokyo 108-8639, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond T.","family":"Chung","sequence":"additional","affiliation":[{"name":"Liver Center and Gastrointestinal Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,9,2]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1021\/cb300610s","article-title":"Kinase drug discovery--what's next in the field?","volume":"8","author":"Alessi","year":"2013","journal-title":"ACS Chem Biol"},{"key":"2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2015.07.010","article-title":"A historical overview of protein kinases and their targeted small molecule inhibitors","volume":"100","author":"Roskoski","year":"2015","journal-title":"Pharmacol Res"},{"key":"3","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1134\/S0006297915020017","article-title":"AMP- activated protein kinase: structure, function, and role in pathological processes","volume":"80","author":"Tribulovich","year":"2015","journal-title":"Biochemistry (Mosc)"},{"key":"4","doi-asserted-by":"crossref","first-page":"4658","DOI":"10.1111\/febs.13534","article-title":"Evidence of cancer-promoting roles for AMPK and related kinases","volume":"282","author":"Murphy","year":"2015","journal-title":"FEBS J"},{"key":"5","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00535-014-1000-9","article-title":"MICA SNPs and the NKG2D system in virus-induced HCC","volume":"50","author":"Kato","year":"2015","journal-title":"J Gastroenterol"},{"key":"6","article-title":"The Rationale for Targeting TGF-beta in Chronic Liver Diseases","author":"Sanchez","year":"2016","journal-title":"Eur J Clin Invest"},{"key":"7","doi-asserted-by":"crossref","first-page":"R15","DOI":"10.1530\/JME-13-0063","article-title":"The regulation and function of the NUAK family","volume":"51","author":"Zhao","year":"2013","journal-title":"J Mol Endocrinol"},{"key":"8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.chom.2009.02.001","article-title":"A functional genomic screen identifies cellular cofactors of hepatitis C virus replication","volume":"5","author":"Chung","year":"2009","journal-title":"Cell Host Microbe"},{"key":"9","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.jhep.2013.06.025","article-title":"The AMPK-related kinase SNARK regulates hepatitis C virus replication and pathogenesis through enhancement of TGF-beta signaling","volume":"59","author":"Chung","year":"2013","journal-title":"J Hepatol"},{"key":"10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Thor","year":"2004","journal-title":"Nat Rev Drug Discov"},{"key":"11","doi-asserted-by":"publisher","first-page":"40907","DOI":"10.18632\/oncotarget.5723","article-title":"Disulfiram inhibits TGF-beta-induced epithelial-mesenchymal transition and stem-like features in breast cancer via ERK\/NF-kappaB\/Snail pathway","volume":"6","author":"Zhang","year":"2015","journal-title":"Oncotarget"},{"key":"12","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1002\/stem.1956","article-title":"Concise review: bullseye: targeting cancer stem cells to improve the treatment of gliomas by repurposing disulfiram","volume":"33","author":"Dunn","year":"2015","journal-title":"Stem Cells"},{"key":"13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1046\/j.1471-4159.2002.01015.x","article-title":"Protective effects of docosahexaenoic acid in staurosporine- induced apoptosis: involvement of phosphatidylinositol-3 kinase pathway","volume":"82","author":"Kim","year":"2002","journal-title":"J Neurochem"},{"key":"14","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1021\/jm701302v","article-title":"Characterization of chemical libraries for luciferase inhibitory activity","volume":"51","author":"Inglese","year":"2008","journal-title":"J Med Chem"},{"key":"15","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1124\/pr.111.005538","article-title":"Aldehyde dehydrogenase inhibitors: a comprehensive review of the pharmacology, mechanism of action, substrate specificity, and clinical application","volume":"64","author":"Vasiliou","year":"2012","journal-title":"Pharmacol Rev"},{"key":"16","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1006\/abio.1994.1042","article-title":"An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct","volume":"216","author":"Rifkin","year":"1994","journal-title":"Anal Biochem"},{"key":"17","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1021\/jacs.6b00299","article-title":"Using an Old Drug to Target a New Drug Site: Application of Disulfiram to Target the Zn-Site in HCV NS5A Protein","volume":"138","author":"Lim","year":"2016","journal-title":"J Am Chem Soc"},{"key":"18","doi-asserted-by":"crossref","first-page":"46742","DOI":"10.1074\/jbc.M404334200","article-title":"Identification of SNF1\/AMP kinase-related kinase as an NF-kappaB-regulated anti-apoptotic kinase involved in CD95-induced motility and invasiveness","volume":"279","author":"Peter","year":"2004","journal-title":"J Biol Chem"},{"key":"19","article-title":"The AMPK-related kinase SNARK regulates muscle mass and myocyte survival","author":"Goodyear","year":"2016","journal-title":"J Clin Invest"},{"key":"20","doi-asserted-by":"crossref","first-page":"6914","DOI":"10.1021\/jm049568z","article-title":"Disulfiram facilitates intracellular Cu uptake and induces apoptosis in human melanoma cells","volume":"47","author":"Farmer","year":"2004","journal-title":"J Med Chem"},{"key":"21","first-page":"58","article-title":"Chimeric mice with humanized livers: a unique tool forandenzyme induction studies","volume":"15","author":"Tateno","year":"2014","journal-title":"Int J Mol Sci"},{"key":"22","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1080\/10428190802087454","article-title":"SNARK, a novel downstream molecule of EBV latent membrane protein 1, is associated with resistance to cancer cell death","volume":"49","author":"Park","year":"2008","journal-title":"Leuk Lymphoma"},{"key":"23","doi-asserted-by":"crossref","first-page":"6597","DOI":"10.1073\/pnas.1007694108","article-title":"AMP kinase-related kinase NUAK2 affects tumor growth, migration, and clinical outcome of human melanoma","volume":"108","author":"Liu","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"24","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1158\/0008-5472.CAN-13-3209","article-title":"NUAK2 Amplification Coupled with PTEN Deficiency Promotes Melanoma Development via CDK Activation","volume":"75","author":"Hearing","year":"2015","journal-title":"Cancer Res"},{"key":"25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1093\/toxsci\/kfq169","article-title":"Dithiocarbamates induce craniofacial abnormalities and downregulate sox9a during zebrafish development","volume":"117","author":"Legler","year":"2010","journal-title":"Toxicol Sci"},{"key":"26","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s12072-013-9426-3","article-title":"Amelioration of hepatic inflammation in a mouse model of NASH using a dithiocarbamate derivative","volume":"7","author":"Rinella","year":"2013","journal-title":"Hepatol Int"},{"key":"27","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/aps.2013.52","article-title":"Disulfiram deregulates HIF- alpha subunits and blunts tumor adaptation to hypoxia in hepatoma cells","volume":"34","author":"Cho","year":"2013","journal-title":"Acta Pharmacol Sin"},{"key":"28","doi-asserted-by":"crossref","first-page":"e84807","DOI":"10.1371\/journal.pone.0084807","article-title":"Disulfiram eradicates tumor-initiating hepatocellular carcinoma cells in ROS-p38 MAPK pathway-dependent and -independent manners","volume":"9","author":"Kaneko","year":"2014","journal-title":"PLoS One"},{"key":"29","article-title":"Anti-proliferative and apoptosis-triggering potential of disulfiram and disulfiram-loaded polysorbate 80- stabilized PLGA nanoparticles on hepatocellular carcinoma Hep3B cell line","author":"Rajagopalan","year":"2016","journal-title":"Nanomedicine"},{"key":"30","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/BF01877380","article-title":"Sodium dithiocarb as adjuvant immunotherapy for high risk breast cancer: a randomized study","volume":"6","author":"Oberling","year":"1993","journal-title":"Biotherapy"},{"key":"31","doi-asserted-by":"crossref","first-page":"e0153416","DOI":"10.1371\/journal.pone.0153416","article-title":"Nanoscale Reaction Vessels Designed for Synthesis of Copper-Drug Complexes Suitable for Preclinical Development","volume":"11","author":"Bally","year":"2016","journal-title":"PLoS One"},{"key":"32","doi-asserted-by":"crossref","first-page":"25147","DOI":"10.1021\/acsami.5b06488","article-title":"A Copper-Mediated Disulfiram-Loaded pH-Triggered PEG-Shedding TAT Peptide-Modified Lipid Nanocapsules for Use in Tumor Therapy","volume":"7","author":"Tang","year":"2015","journal-title":"ACS Appl Mater Interfaces"},{"key":"33","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1055\/s-0034-1394137","article-title":"Molecular profiling of liver tumors: classification and clinical translation for decision making","volume":"34","author":"Llovet","year":"2014","journal-title":"Semin Liver Dis"},{"key":"34","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1634\/theoncologist.2014-0424","article-title":"A phase IIb trial assessing the addition of disulfiram to chemotherapy for the treatment of metastatic non-small cell lung cancer","volume":"20","author":"Peylan-Ramu","year":"2015","journal-title":"Oncologist"},{"key":"35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.drudis.2011.12.010","article-title":"Nonprofit drugs as the salvation of the world's healthcare systems: the case of Antabuse (disulfiram)","volume":"17","author":"Cvek","year":"2011","journal-title":"Drug Discov Today"},{"key":"36","article-title":"A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy","author":"Kim","year":"2016","journal-title":"J Neurooncol"},{"key":"37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1136\/bmj.2.6084.457-d","article-title":"Disulfiram blood levels","volume":"2","author":"Malcolm","year":"1977","journal-title":"Br Med J"},{"key":"38","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/bdd.2510120209","article-title":"Plasma concentrations of disulfiram after injection of suspended micropellets into alcoholic subjects","volume":"12","author":"Chandia","year":"1991","journal-title":"Biopharm Drug Dispos"},{"key":"39","volume-title":"Incorporating Alcohol Pharmacotherapies Into Medical Practice: A Review of the Literature","author":"Center for Substance Abuse Treatment","year":"2009"},{"key":"40","article-title":"Disulfiram and its novel derivative sensitize prostate cancer cells to the growth regulatory mechanisms of the cell by re- expressing the epigenetically repressed tumor suppressor-estrogen receptor beta","author":"Gupta","year":"2015","journal-title":"Mol Carcinog"},{"key":"41","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.msec.2016.03.023","article-title":"The inhibitory effect of disulfiram encapsulated PLGA NPs on tumor growth: Different administration routes","volume":"63","author":"Faghihi","year":"2016","journal-title":"Mater Sci Eng C Mater Biol Appl"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11820","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T14:15:48Z","timestamp":1589292948000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.11820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9,2]]},"references-count":41,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2016,11,15]]}},"alternative-id":["11820","27602492"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.11820","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9,2]]}}}